Bausch Health Company Executives

BHC Stock  CAD 7.02  0.12  1.74%   
Bausch Health employs about 20.3 K people. The company is managed by 21 executives with a total tenure of roughly 16 years. For Bausch Health Companies, management analysis helps investors assess whether leadership decisions support the broader investment thesis or introduce new operating risk. The better read usually comes from comparing management claims with operating results, tenure stability, and capital-allocation outcomes over time.
Thomas Appio  President
President & Co-Head Bausch + Lomb/International
  

Management Team Effectiveness

The company has return on total asset (ROA) of 5.18 % meaning that for every 100 dollars of assets, it generated a profit of $5.18. This is consistent with industry norms. Similarly, it shows a return on equity (ROE) of 43.64 %, meaning that it earned $43.64 on each $100 of shareholder capital deployed.
As of 03/24/2026, Net Income Applicable To Common Shares is forecasted to advance to approximately 164.8 M this year, while Common Stock Shares Outstanding is moving lower toward about 254.8 M.

Outstanding Bonds

Bausch Health Companies may use bonds as part of its capital structure to fund operations, refinance liabilities, or support acquisitions and other long-duration investments. Used together with earnings and cash-flow analysis, the bond stack can reveal whether leverage is a manageable tool or a developing constraint.
Over half of Bausch Health's outstanding shares are owned by institutions. When more than half of a company's float is held by institutions, ownership changes tracked through 13F filings can reflect broader shifts in professional investor sentiment. These filings are publicly available and updated each quarter. The ownership breakdown for Bausch Health shows approximately 66% institutional, 11% insider, and 23% public.
 
Shares in Circulation  
 First Issued
1994-03-31
 Previous Quarter
373.1 M
 Current Value
370.5 M
 Average Shares Outstanding
236.6 M
 Quarterly Volatility
109.7 M
Macro event markers
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Holders Distribution

For Bausch Health Companies, institutional participation can be supportive or destabilizing depending on whether large holders are building conviction or reducing exposure. The better interpretation comes from watching concentration, turnover, and changes in holder behavior instead of assuming institutional ownership is automatically bullish.

Market Cap and Value

Workforce Comparison

Bausch Health Companies takes the leading position in number of employees compared to key competitors. The total workforce of Health Care industry is currently estimated at about 29,306. Bausch Health totals roughly 20,300 in number of employees claiming about 69% of equities under Health Care sector.

Profit Margins

The company has Profit Margin (PM) of 2.0 %, which indicates that even a small decline in its sales could erase profits. . Similarly, it shows Operating Margin (OM) of 26.0 %, which means that operating efficiency produces $26.0 per $100 of revenue.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.810.6833
Fairly Up
Pretty Stable

Benchmark Summation

Operator
This analysis covers sixty-one data points across the selected time horizon. Bausch Health Companies Price Series Summation is a cross summation of Bausch Health price series and its benchmark/peer.

Notable Stakeholders

Stakeholder analysis for Bausch Health is useful because companies often face trade-offs among groups that want very different outcomes from the same business. The stronger interpretation comes from connecting stakeholder presence with management behavior, governance patterns, and changes in the operating story.
Thomas AppioPresident & Co-Head Bausch + Lomb/InternationalProfile
Mirza DautbegovicExecutive COOProfile
John BarresiController, VPProfile
Garen SarafianVP RelationsProfile
Steven LeeController VPProfile
MSc MDChief VPProfile
Jeff HartnessCommercial AccessProfile
Kathleen FitzpatrickExecutive OfficerProfile
Arthur ShannonIR Contact OfficerProfile
Jiny MBASenior MedicalProfile
Tage MDChief RDProfile
William WoodfieldSenior TreasurerProfile
Donald PearlSenior DermatologicsProfile
Robert ButzVP AffairsProfile
JeanJacques CharhonChief OfficerProfile
Aimee LenarExecutive PharmaProfile
Seana CarsonExecutive CounselProfile
Josh CoyleSenior SalixProfile
Graham JacksonSenior OfficerProfile
Thomas VadakethEx CFOProfile
Cees HeimanSenior CanadaProfile

Management Information & Data Sources

Bausch Health is a mid-cap company in Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Executive review focuses on insiders, senior management, and employee signals. Leadership stability matters when evaluating execution against stated business priorities. Bausch Health employs 20,300 people.

For Bausch Health Companies, this section uses periodic company reporting and market reference feeds and standardizes the results for cross-period comparison. Intraday timing differences may exist. Insider and management fields are mapped from published filings and company disclosures.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board
Last reviewed on March 13th, 2026

Workforce Efficiency and Productivity

Investors reviewing Bausch Health Companies can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. Used correctly, manpower metrics can highlight whether growth is being supported by better productivity or by heavier staffing costs.

Bausch Health Manpower Efficiency

Return on Bausch Health Manpower

Revenue Per Employee514.6K
Revenue Per Executive497.4M
Net Income Per Employee7.9K
Net Income Per Executive7.6M
Working Capital Per Employee97.4K
Working Capital Per Executive94.1M

More Resources for Bausch Stock Analysis

A broader look at Bausch Health Companies comes from its financial reports and historical data. These indicators describe how financial results are generated.
Bausch Health has a market cap of 2.56 B, operating margin of 25.79%, current ratio of 1.21. Use Trending Equities to view allocation positioning. Tracking Bausch Health Companies in a portfolio provides context for performance attribution. Position sizing depends on the allocation methodology selected for the portfolio. Broader economic conditions can influence Bausch Health Companies's company valuation — related indicators include signals in inflation.
Bausch Health currently shows ROE of 43.64%, market cap of 2.56 Billion. Bausch Health data on this page supports broader research - the resources below add portfolio-level context. Within the Healthcare space, Bausch Health peer comparison and risk tools below help frame relative strengths and weaknesses. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Value and price for Bausch Health are related but not identical, and they can diverge across cycles. For Bausch Health, key inputs include a P/B ratio of 18.74, a profit margin of 1.53%, ROE of 43.64%, and revenue of 10.45 B.